Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
Nerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinica...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.732213/full |
id |
doaj-82e115ebae2b479090b5715d10580dce |
---|---|
record_format |
Article |
spelling |
doaj-82e115ebae2b479090b5715d10580dce2021-09-10T04:27:17ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-09-011510.3389/fnins.2021.732213732213Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment GuidelinesJulia E. Morgan0Sara C. Wilson1Benjamin J. Travis2Kathryn H. Bagri3Kathleen T. Pagarigan4Hannah M. Belski5Cecelia Jackson6Kevin M. Bounader7Jessica M. Coppola8Eden N. Hornung9James E. Johnson10Hilary S. McCarren11Neuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesComparative Pathology Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNeuroscience Department, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD, United StatesNerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinical protocols for treatment of SE in the specific context of NA poisoning in adult male rats. Treatment with both intramuscular and intravenous benzodiazepines was entirely insufficient to control SE. Second line intervention with valproate (VPA) initially terminated SE in 35% of rats, but seizures always returned. Phenobarbital (PHB) was more effective, with SE terminating in 56% of rats and 19% of rats remaining seizure-free for at least 24 h. The majority of rats demonstrated refractory SE (RSE) and required treatment with a continuous third-line anesthetic. Both ketamine (KET) and propofol (PRO) led to high levels of mortality, and nearly all rats on these therapies had breakthrough seizure activity, demonstrating super-refractory SE (SRSE). For the small subset of rats in which SE was fully resolved, significant improvements over controls were observed in recovery metrics, behavioral assays, and brain pathology. Together these data suggest that NA-induced SE is particularly severe, but aggressive treatment in the intensive care setting can lead to positive functional outcomes for casualties.https://www.frontiersin.org/articles/10.3389/fnins.2021.732213/fullstatus epilepticusrefractoryseizurenerve agentorganophosphatesoman |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Julia E. Morgan Sara C. Wilson Benjamin J. Travis Kathryn H. Bagri Kathleen T. Pagarigan Hannah M. Belski Cecelia Jackson Kevin M. Bounader Jessica M. Coppola Eden N. Hornung James E. Johnson Hilary S. McCarren |
spellingShingle |
Julia E. Morgan Sara C. Wilson Benjamin J. Travis Kathryn H. Bagri Kathleen T. Pagarigan Hannah M. Belski Cecelia Jackson Kevin M. Bounader Jessica M. Coppola Eden N. Hornung James E. Johnson Hilary S. McCarren Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines Frontiers in Neuroscience status epilepticus refractory seizure nerve agent organophosphate soman |
author_facet |
Julia E. Morgan Sara C. Wilson Benjamin J. Travis Kathryn H. Bagri Kathleen T. Pagarigan Hannah M. Belski Cecelia Jackson Kevin M. Bounader Jessica M. Coppola Eden N. Hornung James E. Johnson Hilary S. McCarren |
author_sort |
Julia E. Morgan |
title |
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines |
title_short |
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines |
title_full |
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines |
title_fullStr |
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines |
title_full_unstemmed |
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines |
title_sort |
refractory and super-refractory status epilepticus in nerve agent-poisoned rats following application of standard clinical treatment guidelines |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroscience |
issn |
1662-453X |
publishDate |
2021-09-01 |
description |
Nerve agents (NAs) induce a severe cholinergic crisis that can lead to status epilepticus (SE). Current guidelines for treatment of NA-induced SE only include prehospital benzodiazepines, which may not fully resolve this life-threatening condition. This study examined the efficacy of general clinical protocols for treatment of SE in the specific context of NA poisoning in adult male rats. Treatment with both intramuscular and intravenous benzodiazepines was entirely insufficient to control SE. Second line intervention with valproate (VPA) initially terminated SE in 35% of rats, but seizures always returned. Phenobarbital (PHB) was more effective, with SE terminating in 56% of rats and 19% of rats remaining seizure-free for at least 24 h. The majority of rats demonstrated refractory SE (RSE) and required treatment with a continuous third-line anesthetic. Both ketamine (KET) and propofol (PRO) led to high levels of mortality, and nearly all rats on these therapies had breakthrough seizure activity, demonstrating super-refractory SE (SRSE). For the small subset of rats in which SE was fully resolved, significant improvements over controls were observed in recovery metrics, behavioral assays, and brain pathology. Together these data suggest that NA-induced SE is particularly severe, but aggressive treatment in the intensive care setting can lead to positive functional outcomes for casualties. |
topic |
status epilepticus refractory seizure nerve agent organophosphate soman |
url |
https://www.frontiersin.org/articles/10.3389/fnins.2021.732213/full |
work_keys_str_mv |
AT juliaemorgan refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT saracwilson refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT benjaminjtravis refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT kathrynhbagri refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT kathleentpagarigan refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT hannahmbelski refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT ceceliajackson refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT kevinmbounader refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT jessicamcoppola refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT edennhornung refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT jamesejohnson refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines AT hilarysmccarren refractoryandsuperrefractorystatusepilepticusinnerveagentpoisonedratsfollowingapplicationofstandardclinicaltreatmentguidelines |
_version_ |
1717758743117037568 |